New, Simplified Genetic Test Effectively Screens for Hereditary Cancers
Elsevier | January 21, 2021
A single test can identify sources of genetic variation underlying inherited colon, endometrial, and other cancers
Colon Cancer
New Prognostic Markers for Colon Cancer Identified
Medical University of Vienna | November 16, 2020
Understanding the role lymphoid structures in metastatic colorectal cancer may provide new treatment options
Molecular Basis Underlying Colorectal Cancer Revealed
Hokkaido University | September 16, 2020
Researchers describe a molecular mechanism by which mutations at one site in RNF43 cause cancer—and have also offered a potential method to treat these cancers
Promega Microsatellite Instability Molecular Test, OncoMate™ MSI Dx Analysis System, CE Marked & Available in Europe
Promega Corporation | June 9, 2020
New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies, and can guide treatment decisions for patients with Lynch-associated cancers
Coverage of NGS Cancer Testing Revisited
Kimberly Scott | May 31, 2019
CMS has reopened it's decision on next-generation sequencing in patients with advanced cancers
Blood-Based Colon Cancer Screen Shows Promise
University of Wisconsin-Madison | April 9, 2019
Scientists have identified four blood-based fingerprints associated with the pre-cancerous forms of colon cancer
Evidence Supports 10-Year Screening Interval After a Colonoscopy with Normal Findings
Kaiser Permanente | December 18, 2018
Prior to this study, there was little evidence supporting the 10-year recommended screening interval